Alfred Procopio, Jr. v. Eric K. Shinseki

26 Vet. App. 76, 2012 WL 4882287, 2012 U.S. Vet. App. LEXIS 2140
CourtUnited States Court of Appeals for Veterans Claims
DecidedOctober 16, 2012
Docket11-1253
StatusPublished
Cited by15 cases

This text of 26 Vet. App. 76 (Alfred Procopio, Jr. v. Eric K. Shinseki) is published on Counsel Stack Legal Research, covering United States Court of Appeals for Veterans Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Alfred Procopio, Jr. v. Eric K. Shinseki, 26 Vet. App. 76, 2012 WL 4882287, 2012 U.S. Vet. App. LEXIS 2140 (Cal. 2012).

Opinion

HAGEL, Judge:

Alfred Procopio, Jr., appeals through counsel a March 16, 2011, Board of Veterans’ Appeals (Board) decision denying entitlement to VA benefits for prostate cancer and diabetes mellitus type II with edema, both to include as secondary to herbicide exposure. Record (R.) at 3-15. Mr. Procopio’s Notice of Appeal was timely, and the Court has jurisdiction to review the Board decision pursuant to 38 U.S.C. § 7252(a). Because the Board member conducting the September 2010 hearing did not comply with 38 C.F.R. § 3.103(c)(2) (2010), the Court will vacate the March 16, 2011, Board decision and remand the matter for readjudication consistent with this decision.

I. FACTS

Mr. Procopio served on active duty in the U.S. Navy from September 1963 to August 1967, including service on board the U.S.S. Intrepid off the coast of Viet Nam. 1 R. at 862-63, 1025.

*77 Mr. Procopio filed claims for VA benefits for diabetes mellitus and prostate cancer in October 2006 and October 2007, respectively. R. at 694-97, 999-1015. Specifically, Mr. Procopio asserted that those conditions were caused by his exposure to herbicides in service while aboard the U.S.S. Intrepid in “the Gulf of Tonkin and on the southern coast of Vietnam,” which “was responsible for launching aircraft that sprayed ... Agent Orange.” R. at 696, 1009. A VA regional office attempted to obtain records to verify his allegations, but the National Personnel Records Center indicated that no such records existed. R. at 836. Consequently, in March 2009, the regional office sent Mr. Procopio a letter requesting additional information and evidence pertaining to his exposure to herbicides in service. R. at 368-75.

In response, Mr. Procopio submitted a statement indicating that, while aboard the U.S.S. Intrepid, he “quite frequently handled [herbicides] and the aircraft and equipment that was used to spray these chemicals” and drank “water that was pulled from the Gulf [of Tonkin] and ‘purified’ through co-distillation....” R. at 362. He also submitted an undated study funded by the Australian Department of Veterans’ Affairs (hereinafter the Royal Australian Navy study) indicating that “evaporative distillation [of seawater] may allow [dioxin] ... to enter water supplies and to concentrate in the distillate,” which “provides evidence that contamination via water may have been an important pathway for contamination of [Royal Australian Navy] personnel with [dioxin] on board ships.” R. at 366.

In April 2009, the regional office denied Mr. Procopio’s claims. R. at 354-60. He filed a timely Notice of Disagreement with that decision and included a May 2009 treatment note from his private physician, Dr. Gordon Grado, who opined that Mr. Procopio’s conditions were associated with exposure to Agent Orange on the flight deck of the U.S.S. Intrepid and from water collected from evaporators on that ship. R. at 339-43. In October 2009, the regional office issued a Statement of the Case that continued to deny Mr. Procopio’s claims because there was “no record that [he was] exposed to Agent Orange” and the U.S.S. Intrepid carried “A-1 Skyraiders used for bombing and rocketing targets — not spraying Agent Orange.” R. at 308. Mr. Procopio subsequently perfected his appeal. R. at 281.

In September 2010, Mr. Procopio testified at a Board video conference hearing about his in-service exposure to herbicides. R. at 41-50. At that time, Mr. Procopio submitted a May 2010 treatment note from Dr. Grado that included an impression of “Agent [0]range exposure in Vietnam as [a] Blue Water Sailor” 2 and a treatment plan to “[s]upport [his] history of Agent Orange exposure in [the] military, as I have had many other patients who were ‘Blue Water Sailors’ with Agent Orange *78 exposure while off-shore in Vietnam.” R. at 34. Mr. Procopio subsequently submitted an October 2010 letter from Dr. Grado opining: “If Mr. Procopio was off the coast of Vietnam when Agent Orange was being used and he was therefore exposed to Agent Orange, then [his] prostate cancer can be associated with his Agent Orange exposure.” R. at 22.

In March 2011, the Board issued the decision currently on appeal, which denied entitlement to VA benefits for prostate cancer and diabetes mellitus type II with edema, both to include as secondary to herbicide exposure. R. at 3-15. Specifically, the Board considered and rejected the Royal Australian Navy study as “too general in nature” and Dr. Grado’s opinions as “conditional.” R. at 12.

II. PARTIES’ ARGUMENTS

On appeal, Mr. Procopio essentially posits three arguments. First, he argues that the Board hearing officer violated her duty to “explain fully the issues and suggest the submission of evidence which the claimant may have overlooked” under 38 C.F.R. § 3.103(c)(2) (2010) and Bryant v. Shinseki, 23 Vet.App. 488, 496 (2010). Second, he asserts that the Board provided inadequate reasons or bases for finding that Mr. Procopio was not exposed to herbicides via water distillation aboard the U.S.S. Intrepid. Third, he argues that the Secretary violated the duty to assist by failing to request that the Joint Service Records Research Center verify his exposure to herbicides and failing to make reasonable efforts to discover the method of water distillation used by U.S. Navy ships.

The Secretary disputes each of these arguments. First, he argues that the Board hearing officer adequately explained that exposure to herbicides was the issue on appeal and that Mr. Procopio had actual knowledge of the evidence necessary to substantiate his claim. Second, he contends that the Board adequately addressed the evidence of record, including the Royal Australian Navy study, in support of its finding that Mr. Procopio was not exposed to herbicides. Third, he argues that a Joint Service Records Research Center request is not required by the VA Benefits Adjudication Procedure Manual Rewrite (M21-1MR) in U.S. Navy ship cases and that there is no reasonable possibility of substantiating Mr. Procopio’s claim through further investigation regarding water distillation.

III. ANALYSIS

A. Hearing Officer Duties

Mr. Procopio argues that the Board member who conducted the September 2010 video conference hearing failed to comply with the duties outlined in 38 C.F.R. § 3.103(c)(2) because she “asked no pertinent questions,” “failed to explain that the chief factual issue in the case was whether [he] had actually been exposed to herbicide agents while serving aboard the U.S.S. Intrepid off the coast of Vietnam,” and did not “suggest to [him] that he submit evidence” demonstrating such exposure. Appellant’s Brief (Br.) at 9 (italics added). The Secretary responds that, “[b]ecause [Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

10-42 967
Board of Veterans' Appeals, 2017
Cook v. Snyder
28 Vet. App. 330 (Veterans Claims, 2017)
10-43 296
Board of Veterans' Appeals, 2016
13-14 106
Board of Veterans' Appeals, 2016
14-14 791
Board of Veterans' Appeals, 2016
12-27 737
Board of Veterans' Appeals, 2015
11-06 295
Board of Veterans' Appeals, 2015
11-29 861
Board of Veterans' Appeals, 2015
12-16 145
Board of Veterans' Appeals, 2015
12-22 382
Board of Veterans' Appeals, 2013

Cite This Page — Counsel Stack

Bluebook (online)
26 Vet. App. 76, 2012 WL 4882287, 2012 U.S. Vet. App. LEXIS 2140, Counsel Stack Legal Research, https://law.counselstack.com/opinion/alfred-procopio-jr-v-eric-k-shinseki-cavc-2012.